Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop

Biophysical Journal

Volumn 105, Issue 6, 2013, Pages 1502-1514

  Tamamis, Phanourios ^a   Floudas, Christodoulos A ^a  

^a Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120;

ARTICLE; CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN CONFORMATION; THERMODYNAMICS;

HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, CXCR4; THERMODYNAMICS;

EID: 84884316483     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2013.07.049     Document Type: Article

References (72)

1. D.C. Chan, and D. Fass P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273
2. P.D. Kwong, and R. Wyatt W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 1998 648 659
3. P.D. Kwong, and R. Wyatt W.A. Hendrickson Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates Structure 8 2000 1329 1339
4. C.C. Huang, and M. Tang P.D. Kwong Structure of a V3-containing HIV-1 gp120 core Science 310 2005 1025 1028
5. C.C. Huang, and S.N. Lam P.D. Kwong Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4 Science 317 2007 1930 1934
6. M.T. Dittmar, and A. McKnight P. Simmonds HIV-1 tropism and co-receptor use Nature 385 1997 495 496
7. L.H. Xiao, and S.M. Owen R.B. Lal CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage Virology 240 1998 83 92
8. G. Pollakis, and S. Kang W.A. Paxton N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization J. Biol. Chem. 276 2001 13433 13441
9. T. Cardozo, and T. Kimura S. Zolla-Pazner Structural basis for coreceptor selectivity by the HIV type 1 V3 loop AIDS Res. Hum. Retroviruses 23 2007 415 426
10. D. Edo-Matas, and K.A. van Dort N.A. Kootstra Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants Virology 412 2011 269 277
11. B. Wu, and E.Y.T. Chien R.C. Stevens Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
12. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684
13. S.S. Hwang, and T.J. Boyle B.R. Cullen Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1 Science 253 1991 71 74
14. R.A. Weiss, and P.R. Clapham Hot fusion of HIV Nature 381 1996 647 648
15. B.J. Doranz, and M.J. Orsini R.W. Doms Identification of CXCR4 domains that support coreceptor and chemokine receptor functions J. Virol. 73 1999 2752 2761
16. T. Dragic An overview of the determinants of CCR5 and CXCR4 co-receptor function J. Gen. Virol. 82 2001 1807 1814
17. W.T. Choi, and S. Tian Z. Huang Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors J. Virol. 79 2005 15398 15404
18. S. Tian, and W.T. Choi Z. Huang Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains J. Virol. 79 2005 12667 12673
19. A. Brelot, and N. Heveker M. Alizon Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities J. Biol. Chem. 275 2000 23736 23744
20. D.J. Chabot, and P.F. Zhang C.C. Broder Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates J. Virol. 73 1999 6598 6609
21. N. Zhou, and Z. Luo Z. Huang Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies J. Biol. Chem. 276 2001 42826 42833
22. D.J. Chabot, and H.D. Chen C.C. Broder N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates J. Virol. 74 2000 4404 4413
23. A. Brelot, and N. Heveker M. Alizon Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses J. Virol. 73 1999 2576 2586
24. F. Kajumo, and D.A. Thompson T. Dragic Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4 Virology 271 2000 240 247
25. Z. Lu, and J.F. Berson R.W. Doms Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains Proc. Natl. Acad. Sci. USA 94 1997 6426 6431
26. S. Liu, S. Fan, and Z. Sun Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies J. Mol. Model. 9 2003 329 336
27. A. López de Victoria, and P. Tamamis D. Morikis Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops PLoS ONE 7 2012 e49925
28. O. Hartley, and P.J. Klasse J.P. Moore V3: HIV's switch-hitter AIDS Res. Hum. Retroviruses 21 2005 171 189
29. B. Chandramouli, and G. Chillemi A. Desideri Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120 J. Biomol. Struct. Dyn. 29 2012 879 891
30. B. Chandramouli, and G. Chillemi A. Desideri Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120 J. Biomol. Struct. Dyn. 31 2013 403 413
31. A. López de Victoria, and C.A. Kieslich D. Morikis Clustering of HIV-1 subtypes Based on gp120 V3 loop electrostatic properties BMC Biophys 5 2012 3
32. K.B. Napier, and Z.X. Wang J.O. Trent CCR5 interactions with the variable 3 loop of gp120 J. Mol. Model. 13 2007 29 41
33. D. Morikis, and A.K. Rizos E. Krambovitis Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5 Int. J. Mol. Med. 19 2007 343 351
34. S.H. Xiang, and B. Pacheco J. Sodroski Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2 Virology 438 2013 5 13
35. Y. Pan, and B. Ma R. Nussinov Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain J. Biol. Chem. 279 2004 30523 30530
36. Y. Pan, B. Ma, and R. Nussinov CD4 binding partially locks the bridging sheet in gp120 but leaves the β2/3 strands flexible J. Mol. Biol. 350 2005 514 527
37. H.X. Liao, and R. Lynch B.F. Haynes Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Nature 496 2013 469 476 10.1038/nature12053
38. W. Li, and A. Godzik CD-HIT: a fast program for clustering and comparing large sets of protein or nucleotide sequences Bioinformatics 22 2006 1658 1659
39. C.T. Veldkamp, and C. Seibert B.F. Volkman Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12 Sci. Signal. 1 2008 ra4
40. Y. Choi, and C.M. Deane FREAD revisited: accurate loop structure prediction using a database search algorithm Proteins 78 2010 1431 1440
41. A. Roy, A. Kucukural, and Y. Zhang I-TASSER: a unified platform for automated protein structure and function prediction Nat. Protoc. 5 2010 725 738
42. U. Hansmann Parallel tempering algorithm for conformational studies of biological molecules Chem. Phys. Lett. 281 1997 140 150
43. Y. Sugita, and Y. Okamoto Replica-exchange molecular dynamics method for protein folding Chem. Phys. Lett. 314 1999 141 151
44. H. Nymeyer, S. Gnanakaran, and A.E. García Atomic simulations of protein folding, using the replica exchange algorithm Methods Enzymol. 383 2004 119 149
45. G. Pieridou, and C. Avgousti-Menelaou S.C. Hayes UV resonance Raman study of TTR(105-115) structural evolution as a function of temperature J. Phys. Chem. B 115 2011 4088 4098
46. U. Haberthür, and A.J. Caflisch FACTS: fast analytical continuum treatment of solvation J. Comput. Chem. 29 2008 701 715
47. P. Tamamis, and L. Adler-Abramovich G. Archontis Self-assembly of phenylalanine oligopeptides: insights from experiments and simulations Biophys. J. 96 2009 5020 5029
48. P. Tamamis, and E. Kasotakis G. Archontis Amyloid-like self-assembly of peptide sequences from the adenovirus fiber shaft: insights from molecular dynamics simulations J. Phys. Chem. B 113 2009 15639 15647
49. P. Tamamis, and G. Archontis Amyloid-like self-assembly of a dodecapeptide sequence from the adenovirus fiber shaft: perspectives from molecular dynamics simulations J. Non-Cryst. Solids 357 2011 717 722
50. B.R. Brooks, and C.L. Brooks 3rd M.J. Karplus CHARMM: the biomolecular simulation program J. Comput. Chem. 30 2009 1545 1614
51. S.R. Comeau, and D.W. Gatchell C.J. Camacho CLUSPRO: an automated docking and discrimination method for the prediction of protein complexes Bioinformatics 20 2004 45 50
52. W. Im, M.S. Lee, and C.L. Brooks 3rd Generalized Born model with a simple smoothing function J. Comput. Chem. 24 2003 1691 1702
53. W. Im, M. Feig, and C.L. Brooks 3rd An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins Biophys. J. 85 2003 2900 2918
54. M. Michino, and J. Chen C.L. Brooks 3rd FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A Proteins 78 2010 2189 2201
55. M. Seeber, and M. Cecchini A. Caflisch WORDOM: a program for efficient analysis of molecular dynamics simulations Bioinformatics 23 2007 2625 2627
56. B.G. Pierce, Y. Hourai, and Z. Weng Accelerating protein docking in ZDOCK using an advanced 3D convolution library PLoS ONE 6 2011 e24657
57. I. Massova, and P.A. Kollman Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding Perspect. Drug Discov. 18 2000 113 135
58. M.K. Gilson, and H.X. Zhou Calculation of protein-ligand binding affinities Annu. Rev. Biophys. Biomed. 36 2007 21 42
59. V. Zoete, M.B. Irving, and O. Michielin MM-GBSA binding free energy decomposition and T cell receptor engineering J. Mol. Recognit. 23 2010 142 152
60. H. Gohlke, and D.A. Case Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf J. Comput. Chem. 25 2004 238 250
61. C.S. Page, and P.A. Bates Can MM-PBSA calculations predict the specificities of protein kinase inhibitors? J. Comput. Chem. 27 2006 1990 2007
62. P. Tamamis, and A. López de Victoria G. Archontis Molecular dynamics in drug design: new generations of compstatin analogs Chem. Biol. Drug Des. 79 2012 703 718
63. P. Tamamis, and D. Morikis G. Archontis Species specificity of the complement inhibitor compstatin investigated by all-atom molecular dynamics simulations Proteins 78 2010 2655 2667
64. P. Tamamis, and P. Pierou G. Archontis Design of a modified mouse protein with ligand binding properties of its human analog by molecular dynamics simulations: the case of C3 inhibition by compstatin Proteins 79 2011 3166 3179
65. W. Humphrey, A. Dalke, and K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38 27-28
66. E. Oberlin, and A. Amara B. Moser The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 Nature 382 1996 833 835
67. C.C. Bleul, and M. Farzan T.A. Springer The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382 1996 829 833
68. W.T. Choi, and S. Kumar J. An A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry Biochemistry 51 2012 7078 7086
69. K. Bozek, and T. Lengauer F.S. Domingues Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage PLOS Comput. Biol. 9 2013 e1002977
70. F. Cocchi, and A.L. DeVico P. Lusso The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection Nat. Med. 2 1996 1244 1247
71. M.L. Bellows, and M.S. Taylor C.A. Floudas Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework Biophys. J. 99 2010 3445 3453
72. M.L. Bellows-Peterson, and H.K. Fung T.M. Woodruff De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation J. Med. Chem. 55 2012 4159 4168